Tuning the Drug Release from Antibacterial Polycaprolactone/Rifampicin Core-Shell Electrospun Membranes

Published in ACS Applied Materials & Interfaces (2022) · American Chemical Society · Open access, CC BY
DOI: 10.1021/acsami.2c04849

Summary

Coaxial fibres are attractive for guided tissue regeneration because a bioactive compound can be protected inside the core and released over a long period rather than dumped at once. This study builds antibacterial coaxial membranes of poly-ε-caprolactone loaded with rifampicin, and asks a specific question: does it matter whether the drug sits in the core or in the shell? Both configurations were compared against non-coaxial matrices, showing how the position of the drug within the fibre - not just its quantity - governs the release profile and the duration of antibacterial activity.

Authors & Affiliations

  • Martina Gruppuso
    Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy
  • Benedetta Guagnini
    Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy
  • Luigi Musciacchio
    Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy
  • Francesco Bellemo
    Department of Engineering and Architecture, University of Trieste, Italy
  • Gianluca Turco
    Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy
  • Davide Porrelli Corresponding
    Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy

Linari Electrospinning Systems

Coaxial electrospinning needles by Linari NanoTech
The coaxial membranes were produced using equipment from Linari NanoTech (Pisa, Italy). Feeding the drug through the core while spinning the shell from a separate solution is exactly what our coaxial needles are designed for.

Topics

Coaxial Electrospinning Controlled Drug Release Antibacterial Membranes Guided Tissue Regeneration

Materials

Poly(epsilon-caprolactone) Rifampicin
Read the full publication
Back to blog